Fabry Disease symptoms in adults
Fabry disease is a rare inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A. This enzyme deficiency leads to the accumulation of a fatty substance called globotriaosylceramide (GL-3 or Gb3) within various tissues and organs, resulting in a wide array of symptoms. Although it is often diagnosed in childhood, many adults may live with undiagnosed or misdiagnosed symptoms for years. Understanding the manifestations of Fabry disease in adults is crucial for timely diagnosis and management.
In adults, one of the earliest and most characteristic symptoms is pain. This pain often manifests as burning, tingling, or stabbing sensations predominantly in the hands and feet, a condition known as acroparesthesias. These neuropathic pains can be severe and may occur spontaneously or be triggered by fever, exercise, or stress. Over time, nerve damage can lead to decreased sensation or numbness, complicating the clinical picture.
Skin-related symptoms are also common. Adults with Fabry disease may develop angiokeratomas—small, dark red or purple skin lesions that resemble clusters of blood vessels—primarily located on the lower abdomen, groin, or thighs. These skin abnormalities are a hallmark of the disease and can be a visual cue for diagnosis. Additionally, excessive sweating (hypohidrosis) or episodes of reduced sweating (anhidrosis) are frequently reported, which can impair temperature regulation.
Cardiovascular issues are prominent in adult Fabry patients. The disease can cause left ventricular hypertrophy (thickening of the heart muscle), leading to symptoms such as chest pain, shortness of breath, fatigue, and arrhythmias. Some adults may also develop high blood pressure or experience episodes of fainting. Over time, these cardiac complications can lead to heart failure if not properly managed.
Renal involvement is another significant concern. Fabry disease can cause progressive kidney damage, often presenting as proteinuria (protein in the urine), hypertension, or declining kidney function. In advanced stages, this may culminate in chronic kidney disease or failure, necessitating dialysis or transplantation.
The nervous system’s involvement can extend beyond peripheral neuropathy. In adults, cerebrovascular complications such as strokes are notable risks. Small vessel disease caused by lipid accumulation can lead to transient ischemic attacks or full-blown strokes, often at a younger age than typical in the general population. Cognitive changes and dizziness may also be observed.
Gastrointestinal symptoms are not uncommon, with adults reporting abdominal pain, diarrhea, or bloating. These symptoms result from Gb3 deposits affecting the gastrointestinal tract and can contribute to overall discomfort.
In summary, Fabry disease in adults presents with a complex and multisystemic symptom profile. Early recognition of these symptoms—especially pain, skin lesions, cardiac, renal, and neurological signs—can prompt further diagnostic testing, such as enzyme activity assays or genetic analysis. Early intervention with enzyme replacement therapy or other treatments can significantly improve quality of life and slow disease progression.
Understanding the diverse manifestations of Fabry disease in adults underscores the importance of awareness among healthcare providers and patients alike. Timely diagnosis and management are vital in mitigating long-term complications and enhancing patient outcomes.
